BEXIMCO PHARMA.GDR REGS 1 Working Capital to Net Assets Ratio
BEXIMCO PHARMA.GDR REGS 1 working capital to net assets ratio. BEXIMCO PHARMA.GDR REGS 1 (R2WA) has a Working Capital to Net Assets ratio of 24.4% as of December 2024. Working capital of €13.09 Billion (current assets of €24.63 Billion minus current liabilities of €11.54 Billion) is measured against net assets of €53.63 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check BEXIMCO PHARMA.GDR REGS 1 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of BEXIMCO PHARMA.GDR REGS 1 (2021–2024)
Working capital to net assets ratio of BEXIMCO PHARMA.GDR REGS 1 from 2021 to 2024. This chart shows how BEXIMCO PHARMA.GDR REGS 1's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2021 to 2024. As of December 2024, the ratio stands at 24.4%, reflecting working capital of €13.09 Billion against net assets of €53.63 Billion EUR. See how many days can BEXIMCO PHARMA.GDR REGS 1 fund operations to measure how many days the company can operate on defensive assets alone.
BEXIMCO PHARMA.GDR REGS 1 Working Capital to Net Assets Ratio by Year (2021–2024)
BEXIMCO PHARMA.GDR REGS 1 working capital to net assets ratio by year from 2021 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for BEXIMCO PHARMA.GDR REGS 1 from 2021 to 2024, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of BEXIMCO PHARMA.GDR REGS 1.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 21.7% | €11.26 Billion | €51.90 Billion | €20.82 Billion | €9.56 Billion | ▲ +5.7 pp |
| 2023 | 16.0% | €7.61 Billion | €47.62 Billion | €20.88 Billion | €13.27 Billion | ▲ +3.2 pp |
| 2022 | 12.7% | €5.68 Billion | €44.64 Billion | €18.42 Billion | €12.74 Billion | ▲ +0.9 pp |
| 2021 | 11.8% | €4.42 Billion | €37.36 Billion | €13.77 Billion | €9.35 Billion | — |